Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

(Reuters) -The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV treatments due to low levels of a type of white blood cell in ...

(Reuters) - An advocacy group concerned about costs and possible health problems related to a drug being considered to help stop the spread of HIV infection to healthy people has asked U.S. regulators ...

The HIV-prevention pill PrEP will now be covered under most insurance plans. Its name is short for pre-exposure prophylaxis. Supporters of the move to make it free to those who are insured call it a ...

AIDS prevention got a boost last year when researchers reported that the daily combination anti-HIV pill Truvada, which is designed to treat the disease, may actually be able to prevent HIV infection ...

KOLKATA, May 4 (Thomson Reuters Foundation) - Every morning, Neharika Ravalkar takes a pill that stops her joining the millions of Indians who are HIV-positive. As a trans woman, Ravalkar is among the ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — Doctors should offer a ...